Global leader within orthopedic implants and instruments for pets

Ossium

Ossium Group (“Ossium”) was created by Fidelio through the acquisition of three companies located in Switzerland and the U.S. during 2019 and 2020, creating a global leader within veterinary orthopedic implants.

In addition to designing and distributing veterinary orthopedic implants and instruments, Ossium runs educational seminars to educate and train veterinarians in the various procedures as well as keeping them up to date of recent product developments.

Boasting a broad product offering ranging from advanced hip implants to sutures, the group will continue to invest in innovation and R&D, and serve the market through best-in-class commercial operations.

Products are sold to veterinarians and animal hospitals in 45+ markets with the largest product groups being implants for hips and knees as well as fracture plates.

CEO: Guy C. Spörri, Chris Sidebotham and Patrick Gendreau
Head office: USA
Employees: 90
Acquisition year: 2019
Acquisitions: 3
Industry: Animal health
Website: kyon.ch, biomedtrix.com, vetimplants.com

Related news

Fidelio acquires Veterinary Orthopedic Implants (…

Fidelio Capital acquires a majority of the shares in VOI. VOI is a leading company within the market for veterinary orthopedic implants and instruments. The company is based in Florida, USA, and sells its products to over 40 markets world-wide.

Read more

Fidelio acquires BioMedtrix

Fidelio Capital acquires a majority of the shares in BioMedtrix. BioMedtrix is a leading company within the market for veterinary orthopedic implants and instruments. The company is based in New Jersey, USA, and sells its products to over 35 markets

Read more

Fidelio acquires Kyon

Fidelio Capital acquires a majority of the shares in Kyon. Kyon is a leading company within the market for veterinary orthopedic implants and instruments. The company is based in Zurich, Switzerland, and sells its products to over 45 markets world-wide.

Read more